On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
On February 6, 2025, Mr. Joseph Grimes, Mr. Sanjay Prasad and Mr. Steven Ritacco, each resigned from the Board of Directors of TRIBAL RIDES INTERNATIONAL CORP.
On February 4, 2025, Arch Capital Group Ltd.’s (“ACGL”) Board of Directors (“Board”) unanimously approved the appointment of Alexander Moczarski to serve as a Class III director of the Board, effective February 4, 2025.
On February 2, 2025, Gail Schulze, a member of the class of directors whose terms of office expire at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”) of Cerus Corporation (the “Company”), informed the Company that she would not stand for re-election at the 2025 Annual Meeting.
On February 5, 2025, Lara H. Balazs notified the Board of Directors of Frontdoor, Inc. (the “Company”) that she does not intend to stand for re-election as a director of the Company when her term expires at the Company’s 2025 annual meeting of stockholders.
On February 4, 2025, Herbert Simon, age 90, a member and Chaiman Emeritus of the Board of Directors (the “Board”) of Simon Property Group, Inc. (the “Company”) notified the Company that he is retiring from the Board, including his position as Chairman Emeritus, effective as of such date.
On February 27, 2024, Mr. Keijiero Varela tendered his resignation, effective March 12, 2024 (the “Effective Date”), as Director of The Cannaisseur Group, Inc. (the “Company”), to pursue other business opportunities.
On December 4, 2024, Mr. Harold "Butch" Woolfolk tendered his resignation, effective December 13, 2024 (the "Effective Date"), as Director of The Cannaisseur Group, Inc. (the "Company"), to pursue other business opportunities.
On February 6, 2025, Sabre Corporation (“Sabre”) announced that Karl Peterson will be retiring from the Board, as well as from all Board committees on which he sits, effective immediately prior to Sabre’s 2025 Annual Meeting of Stockholders, which is scheduled to be held on April 23, 2025.
Departed
Angus C. Russell
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Chris Nolet
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Vlad Coric
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Julian S. Gangolli
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Jill Beraud
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Appointed
Jeffery A Bedard
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Filed
February 6, 2025, 6:59 PM ET
Jeffery A Bedard became the sole director of the Company.
Departed
Olivia C. Ware
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Mark J. Foley
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
Departed
Carey O’Connor Kolaja
director
Revance Therapeutics, Inc.
Effective
2025-02-06
Successor
Jeffery A Bedard
Filed
February 6, 2025, 6:59 PM ET
at the Effective Time, each of the directors of the Company (Angus C. Russell, Chris Nolet, Jill Beraud, Vlad Coric, Mark J. Foley, Julian S. Gangolli, Carey O’Connor Kolaja and Olivia C. Ware) resigned as directors of the Company.
On February 6, 2025, the Board of Directors (the “Board”) of Block, Inc. (the “Company”) increased the size of the Board from nine to ten directors and elected Anthony Eisen to the Board as a Class III director, effective February 6, 2025.
Pursuant to the terms of the Merger Agreement, the Board of Directors (the "Board") of the Company approved an increase of the size of the Board from 7 to 8 members effective February 5, 2025 and filled the newly created vacancy by appointing Peter R. Sachse, as an independent director, to serve on the Board, effective on the same day.
Appointed
Robert McGuire
independent director
Aerkomm Inc.
Effective
2025-02-03
Filed
February 6, 2025, 6:59 PM ET
the Board appointed Mr. Robert McGuire to become an independent member of the Board effectively immediately
Departed
Colin Lim
independent director
Aerkomm Inc.
Filed
February 6, 2025, 6:59 PM ET
recently created by the resignation of two of the Company’s independent directors, Mr. Colin Lim and Mr. Raymond Choy.
Departed
Raymond Choy
independent director
Aerkomm Inc.
Filed
February 6, 2025, 6:59 PM ET
recently created by the resignation of two of the Company’s independent directors, Mr. Colin Lim and Mr. Raymond Choy.
On January 20, 2025, Yingda Wu, a member of the Board of Directors of Kuber Resources Corp. (the “Company”), tendered his resign from the Company's Board of Directors, effective January 20, 2025.
On February 4, 2025, the Board of Directors (the “Board”) of Tecnoglass Inc. (the “Company”) appointed Jon Paul “JP” Pérez to fill the vacancy on the Board created by Lorne A. Weil’s resignation previously disclosed on January 6, 2025.
Departed
Zachary Rome
Director
PaxMedica, Inc.
Effective
2025-01-31
Filed
February 6, 2025, 6:59 PM ET
On January 31, 2025, Zachary Rome resigned from the Board for personal reasons, effective immediately.
On January 31, 2025, the Board of Directors (the “Board”) of Medalist Diversified REIT, Inc. (the “Company”) appointed Marc Carlson, as a Class II director of the Company, effective immediately.
On February 6, 2025, in connection with his departure from Gilead Sciences, Inc. (“Gilead”), Merdad Parsey, M.D., Ph.D., resigned as a member of Arcus Biosciences, Inc.’s (“Arcus”) Board of Directors (the “Board”), effective upon the appointment of Gilead’s new director designee pursuant to the Amended and Restated Investor Rights Agreement dated January 29, 2024 by and between Arcus and Gilead.
Departed
Jaydriane Panis
Director
Virpax Pharmaceuticals, Inc.
Effective
2025-02-03
Successor
Charn Deol
Filed
February 6, 2025, 6:59 PM ET
Jaydriane (Jay) Panis, who resigned from the Board on February 3, 2025.
Appointed
Charn Deol
Director
Virpax Pharmaceuticals, Inc.
Effective
2025-02-05
Filed
February 6, 2025, 6:59 PM ET
appointed Mr. Charn Deol as an independent director of the Company, effective immediately.
On January 31, 2025, William A. Kozy informed the Board of Directors (the "Board") that he will retire as a director, effective on the date of The Cooper Companies, Inc.'s (the "Company's") next Annual Meeting of Stockholders in April 2025 (the "Annual Meeting").
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.